Literature DB >> 16463089

An archived lot of coccidioidin induces specific coccidioidal delayed-type hypersensitivity and correlates with in vitro assays of coccidioidal cellular immune response.

Neil M Ampel1, Richard F Hector, Christina P Lindan, George W Rutherford.   

Abstract

No test for assessing cellular immune response in coccidioidomycosis is currently available in the United States. In the present study, we tested 49 healthy subjects living in the coccidioidal endemic region with a 1:55.8 dilution of a single lot of coccidioidin archived since the 1970s. In this group, 23 evaluable subjects demonstrated >/=5 mm of induration at 24, 48 or 72 h, with a mean+/-SEM maximum induration of 18.4+/-4.0 mm. The induration results among 14 subjects reactive at 24 h were compared to those from 179 individuals in an historical cohort studied in the 1980s using a reference lot of coccidioidin. Results were within 5% and not significantly different (P=0.924). The maximum induration response of all evaluable subjects correlated significantly with the results of in vitro tests of coccidioidal cellular immunity using supernatant interferon-gamma concentration and CD69 expression on T cells (Spearman rank correlation coefficients 0.69 and 0.68, respectively; P<0.01 for both). These data suggest that archived coccidioidin retains its potency and specificity and that in vitro test of coccidioidal immunity may have utility in the measurement of coccidioidal cellular immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16463089     DOI: 10.1007/s11046-005-0218-8

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  28 in total

1.  Cytokine production by peripheral blood mononuclear cells in human coccidioidomycosis.

Authors:  D B Corry; N M Ampel; L Christian; R M Locksley; J N Galgiani
Journal:  J Infect Dis       Date:  1996-08       Impact factor: 5.226

2.  Coccidioidomycosis in Arizona: increase in incidence from 1990 to 1995.

Authors:  N M Ampel; D G Mosley; B England; P D Vertz; K Komatsu; R A Hajjeh
Journal:  Clin Infect Dis       Date:  1998-12       Impact factor: 9.079

3.  Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules.

Authors:  C R Zimmermann; S M Johnson; G W Martens; A G White; B L Zimmer; D Pappagianis
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  Assessment of the human cellular immune response to T27K, a coccidioidal antigen preparation, by flow cytometry of whole blood.

Authors:  N M Ampel; L A Kramer; K M Kerekes; S M Johnson; D Pappagianis
Journal:  Med Mycol       Date:  2001-08       Impact factor: 4.076

Review 5.  Coccidioidomycosis.

Authors:  D A Stevens
Journal:  N Engl J Med       Date:  1995-04-20       Impact factor: 91.245

6.  Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis.

Authors:  Neil M Ampel; Daniel K Nelson; Suzette Chavez; Kathryn A Naus; Amanda B Herman; Lijin Li; Keira A Simmons; Demosthenes Pappagianis
Journal:  Clin Diagn Lab Immunol       Date:  2005-06

7.  Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996.

Authors:  N E Rosenstein; K W Emery; S B Werner; A Kao; R Johnson; D Rogers; D Vugia; A Reingold; R Talbot; B D Plikaytis; B A Perkins; R A Hajjeh
Journal:  Clin Infect Dis       Date:  2001-02-28       Impact factor: 9.079

8.  A coccidioidomycosis outbreak following the Northridge, Calif, earthquake.

Authors:  E Schneider; R A Hajjeh; R A Spiegel; R W Jibson; E L Harp; G A Marshall; R A Gunn; M M McNeil; R W Pinner; R C Baron; R C Burger; L C Hutwagner; C Crump; L Kaufman; S E Reef; G M Feldman; D Pappagianis; S B Werner
Journal:  JAMA       Date:  1997-03-19       Impact factor: 56.272

9.  Thimerosal in the detection of clinically relevant allergic contact reactions.

Authors:  T Suneja; D V Belsito
Journal:  J Am Acad Dermatol       Date:  2001-07       Impact factor: 11.527

10.  Marked increase in cases of coccidioidomycosis in California: 1991, 1992, and 1993.

Authors:  D Pappagianis
Journal:  Clin Infect Dis       Date:  1994-08       Impact factor: 9.079

View more
  10 in total

1.  A reformulated spherule-derived coccidioidin (Spherusol) to detect delayed-type hypersensitivity in coccidioidomycosis.

Authors:  Royce Johnson; Steven M Kernerman; Bradley G Sawtelle; Suresh C Rastogi; H Stewart Nielsen; Neil M Ampel
Journal:  Mycopathologia       Date:  2012-06-06       Impact factor: 2.574

2.  Clinical comparison of two Mexican coccidioidins.

Authors:  Laura Rosío Castañón-Olivares; Rafael Laniado-Laborín; Toriello Concepcion; Bertha Muñoz-Hernández; Arturo Aroch-Calderón; Iván Sammir Aranda-Uribe; María Antonieta Flores-Sánchez; María del Rocío González-Martínez; Alfonso Hernández-Navarez; María Eugenia Manjarrez-Zavala; Sandra Miranda-Mauricio; Gabriel Palma; Amelia Pérez-Mejía
Journal:  Mycopathologia       Date:  2010-02-23       Impact factor: 2.574

3.  Cytokine Profiles from Antigen-Stimulated Whole-Blood Samples among Patients with Pulmonary or Nonmeningeal Disseminated Coccidioidomycosis.

Authors:  Neil M Ampel; Lance A Nesbit; Chinh T Nguyen; Suzette Chavez; Kenneth S Knox; Suzanne M Johnson; Demosthenes Pappagianis
Journal:  Clin Vaccine Immunol       Date:  2015-06-03

4.  Measuring cellular immunity in coccidioidomycosis: the time is now.

Authors:  Neil M Ampel; Richard F Hector
Journal:  Mycopathologia       Date:  2010-02-16       Impact factor: 2.574

5.  Revision and return of a coccidioidal skin test reagent.

Authors:  Demosthenes Pappagianis; Suzanne M Johnson
Journal:  Mycopathologia       Date:  2012-12       Impact factor: 2.574

6.  The utility of fine needle aspiration for diagnosis of extrapulmonary coccidioidomycosis: a case report and discussion.

Authors:  Natasha Berg; Patrick Ryscavage; Piotr Kulesza
Journal:  Clin Med Res       Date:  2011-05-11

7.  Polyfunctional T lymphocytes are in the peripheral blood of donors naturally immune to coccidioidomycosis and are not induced by dendritic cells.

Authors:  Lance Nesbit; Suzanne M Johnson; Demosthenes Pappagianis; Neil M Ampel
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

8.  Distance from construction site and risk for coccidioidomycosis, Arizona, USA.

Authors:  Janis E Blair; Yu-Hui H Chang; Yvette Ruiz; Stacy Duffy; Beth E Heinrich; Douglas F Lake
Journal:  Emerg Infect Dis       Date:  2014-09       Impact factor: 6.883

Review 9.  Coccidioidomycosis: Changing Concepts and Knowledge Gaps.

Authors:  Neil M Ampel
Journal:  J Fungi (Basel)       Date:  2020-12-10

10.  Ex Vivo Cytokine Release, Determined by a Multiplex Cytokine Assay, in Response to Coccidioidal Antigen Stimulation of Whole Blood among Subjects with Recently Diagnosed Primary Pulmonary Coccidioidomycosis.

Authors:  Neil M Ampel; Ian Robey; Chinh T Nguyen; Brentin Roller; Jessica August; Kenneth S Knox; Demosthenes Pappagianis
Journal:  mSphere       Date:  2018-05-16       Impact factor: 4.389

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.